We are live on ! Find out more
PLSE icon

Pulse Biosciences
PLSE

62 hedge funds and large institutions have $41.5M invested in Pulse Biosciences in 2024 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 24 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 3

105% more call options, than puts

Call options by funds: $2.42M | Put options by funds: $1.18M

24% more funds holding

Funds holding: 50 → 62 (+12)

0.57% more ownership

Funds ownership: 8.1% → 8.67% (+0.57%)

23% less capital invested

Capital invested by funds: $53.9M → $41.5M (-$12.4M)

58% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 24

Holders
62
Holders Change
+12
Holders Change %
+24%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
10
Reduced
24
Closed
3
Calls
$2.42M
Puts
$1.18M
Net Calls
+$1.24M
Net Calls Change
-$1.16M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.74M
2
Renaissance Technologies
Renaissance Technologies
New York
+$564K
3
Citadel Advisors
Citadel Advisors
Florida
+$463K
4
Millennium Management
Millennium Management
New York
+$380K
5
GAM
Griffin Asset Management
New York
+$374K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$495K
2
Osaic Holdings
Osaic Holdings
Arizona
-$323K
3
BlackRock
BlackRock
New York
-$248K
4
Bank of America
Bank of America
North Carolina
-$200K
5
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
-$129K
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
51
Russell Investments Group
United Kingdom
$11.7K -$515 -56 -4%
AIP
52
Ameritas Investment Partners
Nebraska
$11.6K – – –
OCM
53
Osterweis Capital Management
California
$8.71K – – –
MLICM
54
Metropolitan Life Insurance Company (MetLife)
New York
$8.61K – – –
TRCT
55
Tower Research Capital (TRC)
New York
$5.33K -$19.8K -2,155 -78%
AB
56
Amalgamated Bank
New York
$5K -$10K -1,089 -67%
SPIA
57
Steward Partners Investment Advisory
New York
$1.55K – – –
LC
58
Lindbrook Capital
California
$1.36K +$1.43K +156 New
CFS
59
CGC Financial Services
Oregon
$1.16K +$1.22K +133 New
Nisa Investment Advisors
60
Nisa Investment Advisors
Missouri
$174 +$184 +20 New
AWM
61
Avior Wealth Management
Nebraska
$26 +$28 +3 New
Mirae Asset Global Investments
62
Mirae Asset Global Investments
South Korea
– -$129K -10,571 Closed
BRA
63
Bender Robert & Associates
California
– -$126K -10,325 Closed
LA
64
LM Advisors
California
– -$29.7K -2,430 Closed
Carson Wealth (CWM LLC)
65
Carson Wealth (CWM LLC)
Nebraska
– +$9 +1 New
1 2
3

PLSE Hedge Fund Activity: Q1 2024 in Review

62 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q1 2024, worth a combined $41.5M — down 23% from $53.9M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new PLSE positions and 3 closed out — a net gain of 12 holders — while 10 added to existing stakes and 24 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.74M. The largest seller was Morgan Stanley, cutting an estimated $495K.

  • 62 institutional investors held Pulse Biosciences (PLSE) as of Q1 2024, up from 50 in Q4 2023.
  • Funds reported $41.5M of Pulse Biosciences stock for Q1 2024, down 23% quarter-over-quarter.
  • 15 funds opened new Pulse Biosciences positions in Q1 2024 and 3 closed out, a net change of +12 holders.
  • The largest Pulse Biosciences buyer in Q1 2024 was Vanguard Group, an estimated $1.74M added.
  • The largest Pulse Biosciences seller in Q1 2024 was Morgan Stanley, an estimated $495K sold.

Based on aggregated 13F filings for Q1 2024.